TCM
DGX icon

TruNorth Capital Management’s Quest Diagnostics DGX Stock Holding History

TruNorth Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-239
Closed -$45.5K – 193
2025
Q3 		$45.5K Hold
239
– – 0.01% 202
2025
Q2 		$42.9K Hold
239
– – 0.01% 178
2025
Q1 		$40.4K Hold
239
– – 0.01% 235
2024
Q4 		$36.1K Hold
239
– – 0.01% 177
2024
Q3 		$37.1K Hold
239
– – 0.01% 177
2024
Q2 		$32.7K Buy
+239
New +$32.7K 0.01% 164

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TruNorth Capital Management's DGX Position: Q4 2025 in Review

TruNorth Capital Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 239 shares — an estimated $45.5K sold.

TruNorth Capital Management first reported a position in DGX in Q2 2024 and held it in 6 quarters. The position peaked at $45.5K in Q3 2025. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • TruNorth Capital Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • TruNorth Capital Management sold 239 Quest Diagnostics shares in Q4 2025, an estimated $45.5K.
  • TruNorth Capital Management first reported a position in Quest Diagnostics in Q2 2024 and held it in 6 quarters.
  • TruNorth Capital Management's Quest Diagnostics position peaked at $45.5K in Q3 2025.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on TruNorth Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.